Drug Shortage Report for FENTANYL INJECTION BP

Last updated on 2025-04-05 History
Report ID 241701
Drug Identification Number 02496143
Brand name FENTANYL INJECTION BP
Common or Proper name FENTANYL INJECTION BP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) FENTANYL
Strength(s) 100MCG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR EPIDURAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 AMPOULES X 2 ML
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-11-01
Actual start date
Estimated end date 2025-04-15
Actual end date 2025-04-04
Shortage status Resolved
Updated date 2025-04-05
Company comments Contract coverage is in place.
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-04-05 English Compare
v11 2025-04-04 French Compare
v10 2025-04-04 English Compare
v9 2025-02-27 French Compare
v8 2025-02-27 English Compare
v7 2025-01-23 French Compare
v6 2025-01-23 English Compare
v5 2025-01-09 French Compare
v4 2025-01-09 English Compare
v3 2024-11-02 English Compare
v2 2024-10-31 French Compare
v1 2024-10-31 English Compare

Showing 1 to 12 of 12